#ZydusCadila, submitted New Drug Application to Drug Controller General of India for #Desidustat, an oral small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor for treatment of #anaemia in patients with Chronic Kidney Disease on Dialysis and Not on Dialysis pic.twitter.com/JISXqZfBls— DD News (@DDNewslive) November 23, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)












Quickly


